Which has the lower trailing P/E, ABBV or LLY?

LLY has the lower trailing P/E: ABBV trades at 72.43 and LLY at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or LLY?

Over the past five years, LLY grew revenue faster — ABBV at a 3.69% CAGR versus LLY at 24.42%.

Does ABBV or LLY pay a bigger dividend?

ABBV yields 2.68% and LLY yields 0.60% based on trailing dividends and the latest price.

Is ABBV or LLY more profitable?

LLY runs the higher net margin — ABBV at 9.81% versus LLY at 33.53%.

How have ABBV and LLY total returns compared?

Over the past 10 years, ABBV delivered 19.76% and LLY delivered 32.58% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Eli Lilly and Company (LLY)

A side-by-side comparison of AbbVie Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

LLY

Eli Lilly and Company

$1.05T

$1,115.25HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT

Total return — ABBV vs LLY

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)LLY +1572.7% (+32.5%/yr)LLY compounded faster over this window

ABBV LLY

ABBV vs LLY: by the numbers

•LLY is the larger company ($1.05T vs $454.17B market cap).
•LLY trades at the lower trailing earnings multiple (37.42 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•LLY converts more revenue to profit (33.53% vs 9.81% net margin).
•LLY grew revenue faster over the past five years (24.42% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 0.60%).

Metrics side by side

Valuation

Metric	ABBV	LLY
P/E ratio	72.43	37.42
Forward P/E	18.32	30.64
P/S ratio	7.05	13.18
P/B ratio	N/A	31.00
EV / EBITDA	19.34	29.91
FCF yield	3.99%	1.91%

Profitability

Metric	ABBV	LLY
Gross margin	71.48%	84.01%
Operating margin	29.32%	43.92%
Net margin	9.81%	33.53%
ROE	N/A	78.84%
ROIC	13.46%	27.38%

Dividends

Metric	ABBV	LLY
Dividend yield	2.68%	0.60%
Payout ratio	192.43%	22.45%

Growth (annualized)

Metric	ABBV	LLY
Revenue CAGR (5Y)	3.69%	24.42%
EPS CAGR (5Y)	-2.79%	28.88%
FCF CAGR (5Y)	0.11%	32.91%
Total return CAGR (5Y)	23.51%	37.46%

Frequently asked

Which has the lower trailing P/E, ABBV or LLY?: LLY has the lower trailing P/E: ABBV trades at 72.43 and LLY at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or LLY?: Over the past five years, LLY grew revenue faster — ABBV at a 3.69% CAGR versus LLY at 24.42%.
Does ABBV or LLY pay a bigger dividend?: ABBV yields 2.68% and LLY yields 0.60% based on trailing dividends and the latest price.
Is ABBV or LLY more profitable?: LLY runs the higher net margin — ABBV at 9.81% versus LLY at 33.53%.
How have ABBV and LLY total returns compared?: Over the past 10 years, ABBV delivered 19.76% and LLY delivered 32.58% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Eli Lilly P/E ratio AbbVie dividend yield Eli Lilly dividend yield AbbVie ROE Eli Lilly ROE AbbVie operating margin Eli Lilly operating margin AbbVie revenue growth Eli Lilly revenue growth AbbVie free cash flow Eli Lilly free cash flow

AbbVie & Eli Lilly appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.